Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reply to “Noncancer comparators in cancer survivorship studies”

(2022)10.1002/cncr.34254Source: DataRank Database

Reply to “Noncancer comparators in cancer survivorship studies” is a research paper (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Topics (5)IDs (PubMed)

Context only (not used in score)

Findable (1/2)

Accessible (1/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

We only score data papers we can read in full — never from an abstract alone.

Ashly C. Westrick ORCID,Aalap Doshi,Katrina R. Ellis ORCID,Carly R. Jones,Elizabeth W. LaPensee

Live enrichment

National Cancer Institute

Grant: P30CA046592

National Cancer Institute

Grant: R03CA241841

National Cancer Institute

Grant: T32CA236621

National Center for Advancing Translational Sciences

Grant: UL1TR002240

National Institute on Aging

Grant: P30AG015281

MeSH Terms

HumansNeoplasmsResearchCancer SurvivorsSurvivorship